INSM
HEALTHCAREInsmed Inc
$137.09-2.35 (-1.69%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving INSM Today?
No stock-specific AI insight has been generated for INSM yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$64.85$212.75
$137.09
Fundamentals
Market Cap$22.7B
P/E Ratio—
EPS$-6.42
Dividend Yield—
Dividend / Share—
ROE-2.5%
Profit Margin-2.1%
Debt / Equity—
Trading
Volume2.3M
Avg Volume (10D)—
Shares Outstanding215.9M
INSM News
21 articles- Insmed's Q1 Earnings Beat, Sales Miss Estimates, Stock Tanks 23%Yahoo Finance·May 8, 2026
- S&P Futures Climb With All Eyes on Key U.S. Jobs ReportBarchart·May 8, 2026
- US Stock Market Today: S&P 500 Futures Climb As Traders Weigh Jobs And InflationYahoo Finance·May 8, 2026
- Insmed Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- Insmed Incorporated Q1 2026 Earnings Call SummaryMoby·May 7, 2026
- Insmed Tanks On Its Most Important Launch; Why Analysts Remain BullishYahoo Finance·May 7, 2026
- Insmed (INSM) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·May 7, 2026
- Insmed Reports First-Quarter 2026 Financial Results and Provides Business UpdateYahoo Finance·May 7, 2026
- Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of BronchiectasisYahoo Finance·May 6, 2026
- Avalo shares spike on skin drug data; BioNTech to cut staffBiopharmadive·May 6, 2026
- Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026Yahoo Finance·May 4, 2026
- Raymond James Starts Insmed (INSM) at Outperform, Citing Limited CompetitionYahoo Finance·May 2, 2026
- Vanguard’s Larger Passive Stake Puts Insmed’s Volatile Story In FocusYahoo Finance·May 2, 2026
- Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Yahoo Finance·Apr 30, 2026
- Cartesian Therapeutics, Inc. (RNAC) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·Apr 30, 2026
- Insmed to Present at May 2026 Investor ConferencesYahoo Finance·Apr 30, 2026
- Insmed Incorporated (INSM) PT Lifted to $230 as Guggenheim Updates Biotech Earnings ModelsYahoo Finance·Apr 24, 2026
- How The Insmed (INSM) Investment Story Is Shifting On Brinsupri And ENCORE DevelopmentsYahoo Finance·Apr 24, 2026
- Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026Yahoo Finance·Apr 23, 2026
- Stanley Druckenmiller Made 1 Huge Bet That Still Looks Attractive Today and Cut 2 Top Positions247 Wall St·Apr 13, 2026
- Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsightGlobeNewswire Inc.·Apr 8, 2026
All 21 articles loaded
Price Data
Open$138.46
Previous Close$139.44
Day High$142.58
Day Low$136.73
52 Week High$212.75
52 Week Low$64.85
52-Week Range
$64.85$212.75
$137.09
Fundamentals
Market Cap$22.7B
P/E Ratio—
EPS$-6.42
Dividend Yield—
Dividend / Share—
ROE-2.5%
Profit Margin-2.1%
Debt / Equity—
Trading
Volume2.3M
Avg Volume (10D)—
Shares Outstanding215.9M
About Insmed Inc
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—